Description: Annex I, Chapter II, Paragraph 10.4 of the MDR specifies the handling of CMR substances (carcinogenic, mutagenic and reproductive harm). In addition, parallel legislation (REACH, CLP, BPR, etc.) must be observed, in which new substances are currently the focus. The effects of this have, in some cases, significant effects on the medical device industry.

Organiser: BVMed Academy

Location: Online

Online registration: https://event.bvmed-akademie.de/Events/Register/fde3312d-abf3-4589-8d31-f26c99c6399b